Vimarsana
Biggest News Aggregation in the World

Page 32 - Cohort Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cohort Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cohort Study Today - Breaking & Trending Today

Global Clinical Trials Market Research Report to 2026 - Featuring Accell Clinical Research, Clinipace and Icon PLC Among Others - Vimarsana News

Global Clinical Trials Market Research Report to 2026 - Featuring Accell Clinical Research, Clinipace and Icon PLC Among Others

/PRNewswire/ -- The "Clinical Trials Market Research Report by Design, by Phase, by Indication, by Region - Global Forecast to 2026 - Cumulative Impact of...

Athena Bioscience Announces Launch of Nexiclon™ XR, the Only Once-Daily Clonidine Extended-Release Tablets for Treatment of Hypertension - Vimarsana News

Athena Bioscience Announces Launch of Nexiclon™ XR, the Only Once-Daily Clonidine Extended-Release Tablets for Treatment of Hypertension

/PRNewswire/ -- Athena Bioscience, LLC announced plans for the commercial launch of Nexiclon XR, the only once-daily clonidine extended-release tablets...

Long COVID: Spiking heart rate could be a symptom - Vimarsana News

Long COVID: Spiking heart rate could be a symptom

Many who are on the mend from COVID-19 may have noticed a sudden, unexplained spiking of their heart rate, something experts say could just be part of the healing process, or could be a symptom of long COVID.

Source: ctvnews.ca
What we know — and what we still need to learn — about long COVID - Vimarsana News

What we know — and what we still need to learn — about long COVID

A B.C. doctor says as more people become infected, more research is needed to understand the impacts of long COVID.

Source: cbc.ca
Frontiers | Changes in Serum Neutralizing Antibodies Levels During Convalescence of COVID-19 Patients - Vimarsana News

Frontiers | Changes in Serum Neutralizing Antibodies Levels During Convalescence of COVID-19 Patients

Detection of serum-specific SARS-CoV-2 antibody has become a complementary means for the identification of coronavirus disease 2019 (COVID-19). As we already know, the neutralizing antibody titers in patients with COVID-19 decrease during the course of time after convalescence, whereas the duration of antibody responses in the convalescent patients has not been defined clearly. In the current study, we collected 148 serum samples from 37 confirmed COVID-19 cases with different disease severities. The neutralizing antibodies (Nabs), IgM and IgG against COVID-19 were determined by CLIA Micropart...